Funding Opportunities

Canadian and International Funding Oppportunities

Numerous Canadian and international funding opportunities are available for HIV vaccine investigators. In this section you will find brief information on funding opportunities where an individual or a group of researchers can apply for support. Check with the organizations regarding application processes and deadlines.

National Institute of Allergy and Infectious Diseases (NIAID)

The National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world. NIAID is one of the 27 Institutes and Centers of the National Institutes of Health (NIH).

International AIDS Society: CIPHER Grant Program 

With the generous support of an unrestricted grant from the ViiV Healthcare Paediatric Innovation Seed Fund, the Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Grant Programme was established in 2012 to provide a total of US$1 million for research projects that address priority research gaps in paediatric HIV. The CIPHER grant offers early-stage investigators up to $75,000 each for up to two years of research. 

CIHR Canadian HIV Trials Network: Postdoctoral Fellowship Awards Program

The CTN Postdoctoral Fellowship Awards Program facilitates research in HIV and related health conditions by providing funding to candidates who wish to write a trial protocol, research program, and develop and run their own trial. Each award is worth $50,000 plus up to $5,000 in travel allowance on expenses claimed. The fellowships provide career support and are renewable for up to two years. Former CTN postdoctoral fellows from the last two decades include some of Canada’s leading HIV clinical investigators today.

Canadian Institutes of Health Research (CIHR) Funding

The Canadian Institutes of Health Research (CIHR) is the Government of Canada's health research investment agency.

CIHR was created in 2000 under the authority of the Canadian Institutes of Health Research Act. It is an independent agency and is accountable to Parliament through the Minister of Health.

Learn more about exciting discoveries that emerged from CIHR's first decade as an organization - Milestones in Canadian Health Research

Our mission is to create new scientific knowledge and to enable its translation into improved health, more effective health services and products, and a strengthened Canadian health care system.

Composed of 13 Institutes, CIHR provides leadership and support to health researchers and trainees across Canada.

CIHR is part of the Health Portfolio which supports the Minister of Health in maintaining and improving the health of Canadians. For more information on the Health Portfolio, visit Health Canada.

CIHR provides funding opportunities for four themes of health research: 

  • Biomedical
  • Clinical 
  • Health systems services
  • Social, cultural, environmental and population health

Ontario HIV Treatment Network Funding

OHTN funds research with real-life impact to improve the health and well-being of people with and at risk of HIV. Community engagement is key to our success. Our research programs emphasize putting research results into action, and building a robust network of scientists and community members with the perspective and skills to inform Ontario's strategic response to HIV.

Grand Challenges Canada 

Grand Challenges Canada supports Bold Ideas with Big Impact in global health. By July 2015, Grand Challenges Canada had supported over 700 projects, totaling over $200 million, implemented in more than 80 countries. We have also leveraged $296 million in additional funding. Our investments are producing results: Over 3.5 million beneficiaries have already accessed our innovative products or services, thousands of lives have been saved and over one hundred and fifty thousand lives have been improved. We anticipate even more impressive outcomes as these innovations move from proof-of-concept to scale.

Research and Training in Tropical Diseases (TDR) Grants 

TDR funds specific research projects in diseases of poverty, which cover infectious diseases and the culture and environment that contribute to these problems. We also support the development of individuals and institutions in the countries where these diseases are prevalent.

European & Developing Countries Clinical Trials Partnership (EDCTP) 

The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.

Canadian Foundation for AIDS Research (CANFAR)

This year, CANFAR has awarded $765,000 to Canadian HIV and AIDS researchers. This funding includes allocations for new research grants (cycle 27) as well as the second-year funding commitments from last year (cycle 26). There are also a number of important projects that CANFAR funds each year in partnership with other organizations across Canada and globally. 

NSERC Canada Graduate Scholarships - Master's Program

NSERC aims to make Canada a country of discoverers and innovators for the benefit of all Canadians. The agency supports university students in their advanced studies, promotes and supports discovery research, and fosters innovation by encouraging Canadian companies to participate and invest in postsecondary research projects. NSERC researchers are on the vanguard of science, building on Canada’s long tradition of scientific excellence.